# Galectin Therapeutics Inc: Form 8-K, filed Aug 4, 2026

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: 8-K
- Filed: 2026-08-04
- Accepted by EDGAR: Aug 4, 2026, 11:50 ET
- Period: 2026-07-31
- Accession: 0001140361-26-031058
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036126031058/ef20079045_8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036126031058/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036126031058/ef20079045_8-k.htm

Filed Aug 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-031058. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.
